Today is a monumental day for the markets. The FOMC rate decision drops this afternoon, and with WTI crude holding above $100 and stubborn inflation data in the mix, the stakes are high. This is exactly why our T5 macro posture is active, our sizing caps are clamped at 6 - 8%, and our dry powder is safely parked earning yield. We don't guess what the Fed will do; we let the announcement land and let our mechanical rules do the heavy lifting.

Meanwhile, the portfolio itself is serving up a masterclass in behavioral discipline.

CoreWeave: Checking the Line, Not the Noise

  • The Cost Basis: $83.00 (acquired December 19, 2025).

  • The Current Price: Hovering near $82.98.

  • The Structural Support: Our trailing stop is locked at a weekly close below $88.00.

When CoreWeave took a sharp single-session hit earlier in the week, the untrained instinct was to panic. But notice what our system does: it completely ignores intraday noise. Because the pullback didn't break our pre-agreed weekly closing threshold, it is categorized as routine macro chop - not a thesis violation. CoreWeave's backing from NVIDIA, its massive $99.4 billion backlog, and soaring enterprise demand for GPU cloud infrastructure provide the structural floor. Until a weekly close breaks our stop, we hold.

UBER: The Patient Limit Order

While macro headlines churn, our watchlist execution is playing out in slow motion.

As a reminder, UBER's CEO recently put $10 million of his own personal cash on the open market at an average price of $70.96. Our pre-agreed limit order has been sitting right at $71.00 ever since, and it remains fully active and intact today.

We don't chase green candles, and we don't panic when an order sits unfilled by a few cents. If today's Fed volatility gives us the CEO's price, the order fills. If it runs away, we wait for the next setup. That is the essence of patient capital.

Prices as of September 15, 2026 close.